Abstract | OBJECTIVE: To study whether an algorithm that includes additional diagnostic information could increase the specificity of the 14-3-3 protein testing in patients suspected to suffer from Creutzfeldt-Jakob disease (CJD). DESIGN: The development of a diagnostic algorithm. METHOD: The 14-3-3 protein was tested in the cerebrospinal fluid from 69 consecutive patients suspected of having CJD. On the basis of a former study and literature research, a diagnostic algorithm was constructed, which restricted the indication for performing the 14-3-3 protein test. RESULTS: By taking into consideration the findings of neuroimaging and routine cerebrospinal fluid examination prior to 14-3-3 testing, the specificity increased to 97% (95%-CI: 85.5-99.9) thus changing the prior probability of having CJD of 35% to a posterior probability of 75-100%, in the case of a positive test result. CONCLUSION: Determining the presence of 14-3-3 protein is a highly sensitive and specific marker for sporadic CJD when used in combination with imaging and cerebrospinal fluid examination.
|
Authors | A W Lemstra, M van Meegen, F Baas, W A van Gool |
Journal | Nederlands tijdschrift voor geneeskunde
(Ned Tijdschr Geneeskd)
Vol. 145
Issue 30
Pg. 1467-71
(Jul 28 2001)
ISSN: 0028-2162 [Print] Netherlands |
Vernacular Title | Een klinisch algoritme voor het gebruik van de 14-3-3-liquortest bij de diagnostiek van de ziekte van Creutzfeldt-Jakob. |
PMID | 11503317
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- 14-3-3 Proteins
- Biomarkers
- Tyrosine 3-Monooxygenase
|
Topics |
- 14-3-3 Proteins
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Algorithms
- Biomarkers
(cerebrospinal fluid)
- Child
- Creutzfeldt-Jakob Syndrome
(cerebrospinal fluid, diagnosis)
- Diagnosis, Differential
- Female
- Humans
- Immunoblotting
- Male
- Middle Aged
- Sensitivity and Specificity
- Tyrosine 3-Monooxygenase
(cerebrospinal fluid)
|